| pubmed-article:17259488 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17259488 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:17259488 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:17259488 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:17259488 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:17259488 | lifeskim:mentions | umls-concept:C1848822 | lld:lifeskim |
| pubmed-article:17259488 | lifeskim:mentions | umls-concept:C0389071 | lld:lifeskim |
| pubmed-article:17259488 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17259488 | pubmed:dateCreated | 2007-1-29 | lld:pubmed |
| pubmed-article:17259488 | pubmed:abstractText | Inflammation is associated with both chronic kidney dysfunction and type 2 diabetes. Adiponectin, a novel circulating anti-inflammatory protein made by adipocytes, has been reported to be lower in diabetic than nondiabetic subjects. In contrast, serum levels of adiponectin are elevated in end-stage renal disease. We sought to investigate the relation between adiponectin and mild to moderate renal dysfunction in men with type 2 diabetes. | lld:pubmed |
| pubmed-article:17259488 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17259488 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17259488 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17259488 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17259488 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17259488 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17259488 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17259488 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17259488 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17259488 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17259488 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:17259488 | pubmed:author | pubmed-author:HuFrank BFB | lld:pubmed |
| pubmed-article:17259488 | pubmed:author | pubmed-author:LinJulieJ | lld:pubmed |
| pubmed-article:17259488 | pubmed:author | pubmed-author:CurhanGaryG | lld:pubmed |
| pubmed-article:17259488 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17259488 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:17259488 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17259488 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17259488 | pubmed:pagination | 239-44 | lld:pubmed |
| pubmed-article:17259488 | pubmed:dateRevised | 2007-12-3 | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:meshHeading | pubmed-meshheading:17259488... | lld:pubmed |
| pubmed-article:17259488 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17259488 | pubmed:articleTitle | Serum adiponectin and renal dysfunction in men with type 2 diabetes. | lld:pubmed |
| pubmed-article:17259488 | pubmed:affiliation | Renal Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. jlin11@partners.org | lld:pubmed |
| pubmed-article:17259488 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17259488 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17259488 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:9370 | entrezgene:pubmed | pubmed-article:17259488 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17259488 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17259488 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17259488 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17259488 | lld:pubmed |
